DOCSLIB.ORG

Download CMI (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download CMI (PDF) PARNATE® TABLETS (Tranylcypromine 10 mg) Consumer Medicine Information WHAT IS IN THIS LEAFLET Do not take Parnate and talk to your Do not give this medicine to anyone else. doctor if you have taken any other Your doctor has prescribed it specifically for This leaflet answers some of the common medicines for the treatment of depression you and your condition. questions about Parnate. It does not contain or anxiety within the last 5 weeks and If you are not sure whether you should all the available information. It does not take have not discussed this with your doctor. start taking this medicine, talk to your the place of talking to your doctor or This includes: doctor. pharmacist. • Selective Serotonin Reuptake Inhibitors Before you start to take it All medicines have risks and benefits. Your (SSRIs), e.g. fluoxetine, paroxetine, Tell your doctor if you have allergies to doctor has weighed the risks of you taking sertraline Parnate against the benefits they expect it any other medicines, foods, preservatives • Serotonin-Norepinephrine Reuptake will have for you. or dyes. Inhibitors (SNRIs), e.g. venlafaxine If you have any concerns about taking this Tell your doctor if you have or have had • tricyclic antidepressants, e.g. medicine, ask your doctor or pharmacist. any of the following medical conditions: clomipramine, imipramine, • diabetes Keep this leaflet with the medicine. amitriptyline, desipramine, dosulepin You may need to read it again. (dothiepin), nortriptyline, trimipramine • epilepsy (condition where you have or doxepin repeated fits or convulsions) WHAT PARNATE IS USED FOR • buspirone hydrochloride • angina (chest pain) Parnate is used to treat symptoms of Do not take Parnate and talk to your • kidney problems depression, especially if treatment with other doctor if: • addiction to drugs or alcohol types of antidepressants has failed. There are • you are taking, or being treated with, any • angle-closure glaucoma (sudden rise in many different types of medicines used to of the following: intra-ocular pressure) treat depression. Parnate belongs to a group - appetite suppressants such as • sugar intolerance. of medicines called monoamine oxidase fenfluramine, dexfenfluramine, Tell your doctor as soon as possible if you inhibitor (MAOI) antidepressants. It contains phentermine (e.g. Duromine), mazindol the active ingredient tranylcypromine. are planning to have any type of surgery. or diethylpropion for weight loss Parnate may interfere with some medicines Depression is longer lasting or more severe - amphetamines, phenylpropanolamine used during surgery. than the ‘low moods’ that everyone has from or other central nervous system time to time. It is thought to be caused by a stimulants Tell your doctor if you are pregnant or chemical imbalance in parts of the brain. The - cold or hayfever medicines, including plan to become pregnant. imbalance affects your whole body and can nose drops or sprays Your doctor will discuss the risks and cause emotional and physical symptoms. - dextromethorphan, contained in many benefits of using Parnate if you are pregnant. You may feel low in spirit, lose interest in cough and cold medicines you can buy If you take this medicine during the last three usual activities, be unable to enjoy life, have without a prescription months of your pregnancy, the general poor appetite or overeat, have disturbed - methyldopa, dopamine, ephedrine or condition of your newborn baby might be sleep, often waking up early, low energy and any other medicine that affects blood affected. feel guilty over nothing. pressure Tell your doctor if you are breastfeeding Parnate corrects the chemical imbalance and - strong pain killers, e.g. pethidine, or planning to breastfeed. helps relieve the symptoms of depression. It codeine, nefopam Your doctor will discuss the risks and is not recommended for the ‘low moods’ that - levodopa (e.g. Madopar or Sinemet) benefits involved. It is not recommended that everyone has from time to time due to the for Parkinson’s disease you breastfeed while taking Parnate as it stress or sadness of everyday life. - carbamazepine, used to treat epilepsy, passes into breast milk. Your doctor may have prescribed Parnate for nerve pain, mania or bipolar disease Taking other medicines another use. - bupropion, used to help stop smoking Tell your doctor or pharmacist if you are - tryptophan, a dietary supplement to Ask your doctor if you have questions taking any other medicines, including any treat depression or anxiety or help you about why Parnate has been prescribed that you get without a prescription from sleep for you. your pharmacy, supermarket or health • you have or have had any of these Parnate is available only with a doctor’s food shop. medical conditions: prescription. Some medicines and Parnate may interfere - a stroke, poor blood flow to the brain, with each other. or frequent headaches BEFORE YOU TAKE PARNATE Tell your doctor or pharmacist if you are - heart disease or high blood pressure taking any of the following: When you must not take it - liver disease - hyperthyroidism (overactive thyroid • any medicine listed under ‘When you Do not take Parnate if you have an allergy gland) must not take it’ to: - blood or bone marrow disorder • guanethidine, reserpine or any other • Parnate or any other medicine containing - porphyria, a rare blood pigment medicine that affects blood pressure tranylcypromine disorder • sedatives, medicines to help you sleep, • any of the ingredients listed at the end of - phaeochromocytoma, an adrenaline reduce anxiety or induce anaesthesia this leaflet. (epinephrine) producing tumour of the • anticholinergic medicines, e.g. atropine, Some of the symptoms of an allergic reaction adrenal gland which are used to treat a range of may include: • you are over 60 years of age. medical conditions • shortness of breath Do not give Parnate to children and • medicines used to treat Parkinson’s • wheezing or difficulty breathing adolescents under 18 years of age. Disease • swelling of the face, lips, tongue or other The safety of Parnate in this age group has • medicines used to treat diabetes not been established. parts of the body • medicines used to treat epilepsy Do not take this medicine after the expiry • rash, itching or hives on the skin. • anticoagulants, used to treat blood date printed on the pack or if the Do not take Parnate if you have taken it or clotting disorders packaging is torn or shows signs of any other MAOI medication (e.g. phenelzine, tampering. • antihistamines, used to treat allergies moclobemide, furazolidone, iproniazid, If it has expired or is damaged, return it to • metrizamide, a contrast medium used in isocarboxazid, nialamide, pargyline, your pharmacist for disposal. medical imaging. procarbazine hydrochloride) before and became unwell. Tell your doctor or These medicines may be affected by Parnate pharmacist before taking the first dose. or may affect how well it works. You may PARNATE® TABLETS Published by MIMS May 2020 1 need different amounts of your medicines, or you were taking it and stopped less than Things to be careful of you may need to take different medicines. two weeks ago. Watch carefully for signs that your Your doctor will advise you. This applies to medicines that you buy depression or anxiety is getting worse, Your doctor and pharmacist have more without a prescription as well as prescription especially in the first few weeks of information on medicines to be careful with medicines. treatment. or avoid while taking Parnate. Tell any other doctors, dentists, and Tell your doctor immediately if you pharmacists who treat you that you are experience any of the following symptoms, HOW TO TAKE PARNATE taking this medicine. especially if they are severe, you have not Follow all directions given to you by your If you are going to have surgery or had these symptoms before or they doctor or pharmacist carefully. emergency treatment, tell your doctor or happen very suddenly: They may differ from the information dentist that you are taking Parnate or • anxiety or agitation have used it in the last two weeks. contained in this leaflet. • panic attacks It may affect other medicines used during If you do not understand the instructions surgery. • difficulty sleeping on the pack, ask your doctor or • hostility or impulsiveness pharmacist for help. Carry an alert card or wear an SOS bracelet, which tells the doctor, dentist or • restlessness How much to take pharmacist you are taking Parnate. • overactive or uninhibited behaviour The usual dose of Parnate is one 10 mg tablet These are helpful if you are in an accident • thoughts of suicide. taken twice a day. and cannot talk. Tell your doctor immediately if you have How to take it You must avoid certain foods and drinks any thoughts about suicide or doing harm Swallow Parnate tablet(s) whole with a full during treatment with Parnate and for at to yourself. glass of water or another liquid. Do not chew least a week after stopping therapy. All thoughts or talk about suicide or violence the tablets. Avoid protein foods that have been aged are serious. The risk is increased in young When to take it or fermented to improve flavour. Also adults aged 18 - 24 years. Improvement may avoid any foods that have caused you not occur during the initial treatment period Parnate tablets are usually taken in the unpleasant reactions previously. morning and at midday. Take the last dose of (usually one to two months). the day not later than 3 pm. This will help While taking Parnate, you should avoid: If you or someone you know is showing avoid sleep disturbances. • matured cheese the following warning signs, either contact How long to take it • meat, fish, poultry, pate or yoghurt that your doctor or a mental health advisor is stale or smells “off” right away or go to the nearest hospital for For depression, the length of treatment will treatment: depend on how quickly your symptoms • protein extracts such as Marmite, • thoughts or talk about death or suicide improve.
Load more

Recommended publications
  • NORPRAMIN® (Desipramine Hydrochloride Tablets USP)
    NORPRAMIN® (desipramine hydrochloride tablets USP) Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of NORPRAMIN or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. NORPRAMIN is not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use.) DESCRIPTION NORPRAMIN® (desipramine hydrochloride USP) is an antidepressant drug of the tricyclic type, and is chemically: 5H-Dibenz[bƒ]azepine-5-propanamine,10,11-dihydro-N-methyl-, monohydrochloride. 1 Reference ID: 3536021 Inactive Ingredients The following inactive ingredients are contained in all dosage strengths: acacia, calcium carbonate, corn starch, D&C Red No. 30 and D&C Yellow No. 10 (except 10 mg and 150 mg), FD&C Blue No. 1 (except 25 mg, 75 mg, and 100 mg), hydrogenated soy oil, iron oxide, light mineral oil, magnesium stearate, mannitol, polyethylene glycol 8000, pregelatinized corn starch, sodium benzoate (except 150 mg), sucrose, talc, titanium dioxide, and other ingredients.
    [Show full text]
  • Heat Related Illness in Psychotropic Medication Users
    Common psychotropic medications which Prevention of Heat can impair your response to heat Related Illness Trade Name Generic Name Abilify aripiprazole During periods of high temperature (85º Asendin amoxapine and above) and humidity, there are things Artane trihexyphenidyl everyone, particularly people at high risk, Aventil, Pamelor nortriptyline should do to lessen the chances of heat Clozaril clozapine illness. Cogentin benztropine Compazine prochlorperazine ¾ Try to stay cool. Desyrel trazodone • Stay in air conditioned areas if Elavil, Limbitrol, possible. If you do not have air Triavil amitriptyline conditioning at home, go to a Eskalith, Lithobid, shopping mall or public library. Lithonate lithium • Keep windows shut and draperies, Geodon ziprasidone shades, or blinds drawn during the Haldol haloperidol heat of the day. Loxitane loxapine • Open windows in the evening or Ludiomil maprotiline night hours when the air outside is Mellaril thioridazine Heat Related Illness cooler. Moban molindone • Move to cooler rooms during the Navane thiothixene in heat of the day. Norpramin desipramine Psychotropic ¾ Avoid overexertion and outdoor Phenergan promethazine activity, particularly during warmer Prolixin fluphenazine Medication Users periods of the day. Risperdal risperidone ¾ Apply sunscreen and lotion as needed. Serentil mesoridazine Seroquel quetiapine ¾ Drink plenty of fluids (avoid coffee, tea, and alcohol). Sinequan doxepin ¾ Dress in loose fitting, light colored Stelazine trifluoperazine clothing. Wear a hat, sunglasses, and Thorazine chlorpromazine other protective clothing. Tofranil imipramine ¾ Take a cool shower or bath. Trilafon perphenazine ¾ Lose weight if you are overweight. Wellbutrin buproprion ¾ Eat regular meals to ensure that you Zyprexa olanzapine Ohio Department of Mental Health have adequate salt and fluids. *Note: This is not an all inclusive list.
    [Show full text]
  • Association of Selective Serotonin Reuptake Inhibitors with the Risk for Spontaneous Intracranial Hemorrhage
    Supplementary Online Content Renoux C, Vahey S, Dell’Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published online December 5, 2016. doi:10.1001/jamaneurol.2016.4529 eMethods 1. List of Antidepressants for Cohort Entry eMethods 2. List of Antidepressants According to the Degree of Serotonin Reuptake Inhibition eMethods 3. Potential Confounding Variables Included in Multivariate Models eMethods 4. Sensitivity Analyses eFigure. Flowchart of Incident Antidepressant (AD) Cohort Definition and Case- Control Selection eTable 1. Crude and Adjusted Rate Ratios of Intracerebral Hemorrhage Associated With Current Use of SSRIs Relative to TCAs eTable 2. Crude and Adjusted Rate Ratios of Subarachnoid Hemorrhage Associated With Current Use of SSRIs Relative to TCAs eTable 3. Crude and Adjusted Rate Ratios of Intracranial Extracerebral Hemorrhage Associated With Current Use of SSRIs Relative to TCAs. eTable 4. Crude and Adjusted Rate Ratios of Intracerebral Hemorrhage Associated With Current Use of Antidepressants With Strong Degree of Inhibition of Serotonin Reuptake Relative to Weak eTable 5. Crude and Adjusted Rate Ratios of Subarachnoid Hemorrhage Associated With Current Use of Antidepressants With Strong Degree of Inhibition of Serotonin Reuptake Relative to Weak eTable 6. Crude and Adjusted Rate Ratios of Intracranial Extracerebral Hemorrhage Associated With Current Use of Antidepressants With Strong Degree of Inhibition of Serotonin Reuptake Relative to Weak This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 eMethods 1.
    [Show full text]
  • 3,2,4 Tricyclic Antidepressants and the Risk of Congenital Malformation
    Tricyclic antidepressants and the risk of congenital malformations CONFIDENTIAL Medicines Adverse Reactions Committee Meeting date 3/12/2020 Agenda item 3.2.4 Title Tricyclic antidepressants and the risk of congenital malformations Submitted by Medsafe Pharmacovigilance Paper type For advice Team Active ingredient Product name Sponsor Amitriptyline Arrow-Amitriptyline Film coated tablet, 10 mg, 25 Teva Pharm (NZ) Ltd mg & 50 mg Amirol Film coated tablet, 10 mg & 25 mg AFT Pharmaceuticals Ltd Clomipramine Apo-Clomipramine Film coated tablet, 10 mg & Apotex NZ Ltd 25 mg Anafranil Tablet, 10 mg Section 29 Dosulepin Dosulepin Mylan Film coated tablet, 75 mg Mylan New Zealand Ltd Dosulepin Mylan Capsule, 25 mg Section 29 Doxepin Anten 50 Capsule, 50 mg Mylan New Zealand Ltd Imipramine Tofranil Coated tablet, 10 mg & 25 mg AFT Pharmaceuticals Ltd Nortriptyline Norpress Tablet, 10 mg & 25 mg Mylan New Zealand Ltd PHARMAC funding Product highlighted in bold above are funded on the Community Schedule. Two products (shown in italics) are funded but only available under Section 29 of the Medicines Act (ie, the products have not been approved by Medsafe). Previous MARC In utero exposure to serotonin reuptake inhibitors and risk of congenital meetings abnormalities 141st meeting March 2010 International action None Prescriber Update The use of antidepressants in pregnancy September 2010 Classification Prescription medicine Usage data The following pregnancy usage data for 2019 was obtained from the National Collections using the Pharmaceutical Dispensing in Pregnancy application in Qlik. The table shows the total number of dispensings, repeat dispensings and number of pregnancies exposed during first trimester (defined as 30 days prior to the estimated pregnancy start date to week 13) for pregnancies that ended in 2019.
    [Show full text]
  • NORPRAMIN® (Desipramine Hydrochloride Tablets USP)
    NORPRAMIN® (desipramine hydrochloride tablets USP) Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of NORPRAMIN or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. NORPRAMIN is not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use.) DESCRIPTION NORPRAMIN® (desipramine hydrochloride USP) is an antidepressant drug of the tricyclic type, and is chemically: 5H-Dibenz[bƒ]azepine-5-propanamine,10,11-dihydro-N-methyl-, monohydrochloride. Inactive Ingredients The following inactive ingredients are contained in all dosage strengths: acacia, calcium carbonate, corn starch, D&C Red No. 30 and D&C Yellow No. 10 (except 10 mg and 150 mg), FD&C Blue No. 1 (except 50 mg, 75 mg, and 100 mg), hydrogenated soy oil, iron oxide, light 1 Reference ID: 3218795 mineral oil, magnesium stearate, mannitol, polyethylene glycol 8000, pregelatinized corn starch, sodium benzoate (except 150 mg), sucrose, talc, titanium dioxide, and other ingredients.
    [Show full text]
  • HEDIS Reference Guide for Primary Care
    2020 HEDIS Reference Guide for Primary Care Antidepressant Medication Management (AMM) Patient Profile MVP members 18 years of age and older, with a diagnosis of major depression, and who are being treated with antidepressant therapy. You need to ensure member compliance in taking their medication. Two rates are reported: The percentage of members who remained on an antidepressant medication for at least 84 days (12 weeks) and the percentage of members who remained on an antidepressant medication for at least 180 days (6 months). How to Implement Best Practices and Improve Performance • Schedule time with the patient and provide educational materials that address the following: º When will the medication start working and how will the patient know that it’s working? º What will it feel like to be on the medication? º How long will the patient need to be on the medication? º What are the possible side-effects and what should the patient do if they experience any? º Stress the importance of continuing medication, even if the patient is feeling better. º Reiterate the importance of attending follow-up visits. • When working with Pediatric patients, you may want the parent/guardian to work with a drug chart and allow patient participation if possible. The chart can show when the patient has taken their medication and can include extra space to document any concerns. Patients/caregivers can use a free mobile app such as MyMedSchedule to track medication lists, chart when taken, set reminders, and track health needs such as recent labs. • Elderly patients may need medication cueing for successful adherence.
    [Show full text]
  • Updated March 16 2017 Drugs of Abuse Screen, Urine Qualitative Average Turnaround Time: 74 Minutes Compound/Class Cutoff (Ng/Ml
    Drugs of Abuse Screen, Urine Qualitative Average Turnaround Time: 74 minutes Compound/Class Cutoff (ng/mL) Compound/Class Cutoff (ng/mL) Amphetamines 1000 Opiates 300 Barbiturates 200 Oxycodone 100 Benzodiazepines 200 PCP 25 Cocaine 300 Propoxyphene 300 Methadone 300 THC 50 Additional Drug Immunoassay Available Buprenorphine 5 Alcohol (urine) 10 mg/dL Cotinine (nicotine metabolite) 500 Alcohol (serum) 10 mg/dL Toxicology Drug Screen, Urine or Serum Qualitative Turnaround Time: 24 hrs Cutoff Cutoff Cutoff Amphetamines Antihistamines Opioids ng/mL ng/mL ng/mL Amphetamine 250 Chlorpheniramine 100 6-monoacetylmorphine 300 Methamphetamine 500 Dextromethorphan 100 Codeine 200 MDA 250 Diphenhydramine 100 Dihydrocodeine 100 MDMA 250 Ephedrine/ Pseudoephedrine 100 Hydromorphone 200 Antiarrhythmics Ranitidine 500 Hydrocodone 100 Diltiazem 50 Pheniramine 25 Morphine 200 Lidocaine 25 Antipsychotics Oxycodone 100 Verapamil 100 Haloperidol 25 Oxymorphone 200 Quinidine/Quinine 500 Olanzapine 200 Noroxycodone 100 Anticonvulsants Quetiapine 25 Buprenorphine/Norbupren 50/300 Pregabalin 1500 Risperidone 100 Fentanyl/Norfentanyl 25/100 Gabapentin 1500 Benzodiazepines Ketamine 25 Antidepressants(non TCA) Alprazolam/ Hydroxyalprazolam 50/200 Meperidine 50 Bupropion 25 Clonazepam/7-amino 200/50 Methadone/EDDP 50/100 Citalopram 100 Chlordiazepoxide 50 Nalbuphine 50 Fluoxetine 200 Diazepam 100 Naloxone 200 Sertraline 50 Nordiazepam 100 Propoxyphene/Norpropox 100/50 Trazodone 25 Oxazepam 200 Tramadol 50 Venlafaxine 50 Temazepam 100 Phenothiazines Antidepressants
    [Show full text]
  • Pharmacological Modification of Blood-Brain Barrier Permeability Following a Cold Lesion Jennifer J
    LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES Pharmacological Modification of Blood-Brain Barrier Permeability Following a Cold Lesion Jennifer J. Raymond, David M. Robertson, Henry B. Dinsdale, and Sukriti Nag ABSTRACT: The effect of desipramine, imidazole, thioridazine and trifluoperazine on blood-brain barrier(BBB) permeability after a 24 hour cold lesion was studied in rats. Changes in BBB permeability were determined using a quantitative horseradish peroxidase (HRP) assay. The four drugs tested did not alter the quantity of HRP in the cortex of control animals, or in the contralateral cortex of test animals. However, imidazole, desipramine and trifluoperazine significantly reduced the HRP extravasation in and around the cold lesion. Several mechanisms for this effect are suggested; one possible mechanism common to all these drugs is the reduction of increased vesicular transport in cortical vessels adjacent to the cold lesions. RESUME: L'effet de la desipramine, de I'imidazole, de la thioridazine, et de la trifluoperazine sur la permeability de la barriere h6mato-enc6phalique (BHE) apres une exposition au froid de 24 heures a 6te 6tudi6 chez le rat. Des changements dans la perm6abilit6 de la BHE ont 6t6 calcules en employant un titrage quantitatif de la peroxidase de raifort (PR). Les quatre drogues essaydes n'ont pas modifid la quantite du PR dans le cortex des animaux controles, hi dans le cortex contra-lateral des animaux exp6rimentaux. Cependant, I'imidazole, la desipramine, et le trifluoperazine ont rdduit significativement l'extravasation du PR dans et autour de la lesion par le froid. Plusieurs mecanismes pour expliquer cet effet sont sugger£s; un mecanisme possible qui est commun a toutes ces droques est la reduction du transport vesiculaire augmente dans les vaisseau corticaux adjacent aux atteintes induites par le froid.
    [Show full text]
  • Medications to Avoid Before Skin Testing
    PLEASE STOP ANTIHISTAMINES 5 DAYS PRIOR TO NEW PATIENT APPOINTMENTS OR ALLERGY SKIN TESTING *Do not stop asthma medications or any other medications that do not contain antihistamine! **If you have major hives or swelling, do not stop your antihistamines. ***Please call us if you have questions about any of your medications interfering with skin testing. ****Do not use oil, cream or lotion on the back or arms for 24 hours prior to skin testing. COMMON MEDICATIONS CONTAINING ANTIHISTAMINES • Actifed (chlorpheniramine) • Elavil (amitriptyline) • Advil PM, Advil Allergy • Excedrin PM • Alavert/Claritin (loratadine) • Fexofenadine (Allegra) • Allegra (fexofenadine) • Hydroxyzine (Atarax, Vistaril) • Alka Seltzer P.M. • Imipramine (Tofranil) • Amitriptyline (Elavil) • Levocetirizine (Xyzal) • Antivert (Meclizine) • Loratadine (Claritin) • Astelin Nasal Spray (azelastine) • Meclizine (Antivert, Bonine) • Astepro Nasal Spray (azelastine) • Norpramine (desipramine) • Atarax (hydroxyzine) • Nortriptyline (Pamelor) • Azelastine nose spray (Astepro, Astelin) • Nyquil • Benadryl (diphenhydramine) • Nytol • Bonine (meclizine) • Olopatadine (Patanase nasal spray) • Cetirizine (Zyrtec) • Pamelor (nortriptyline) • Chlorpheniramine (Chlor-Trimeton, Actifed, • Patanase Nasal Spray (olopatadine) Tussionex) • PBZ (pyribenzamine) • Chlor-Trimeton (chlorpheniramine) • Pediacare • Clarinex (desloratadine) • Periactin (Cyproheptadine) • Claritin (loratadine) • Phenergan (promethazine) • Clemastine (Tavist) • Promethazine (Phenergan) • Cogentin (for Parkinson's
    [Show full text]
  • Heat-Related Illness in Individuals Using Psychiatric Medication 2016
    Common psychotropic medications You can prevent that may impair the heat response heat-related illness! Trade Name Generic Name Abilify aripiprazole There are ways to stay cool when the Asendin amoxapine temperature is 85 degrees and above, especially Artane trihexyphenidyl with high humidity: Aventyl, Pamelor nortriptyline In general: Benadryl diphenhydramine • Try to stay in cool places. Brintellix vortioxetine • Eat regular light meals. Celexa citalopram Clozaril, Fazaclo, Versacloz clozapine • Drink plenty of fluids. Cogentin benztropine • Avoid coffee, tea and alcohol. Cymbalta duloxetine When indoors: Desyrel, Oleptro trazodone • Spend time in cooler rooms or air- Elavil amitriptyline conditioned areas. A shopping mall or Effexor venlafaxine library provides a cool place. Eskalith, Lithobid, Lithonate lithium Fanapt iloperidone • Keep windows shut and drapes closed Heat-related Fetzima levomilnacipran during the day. Geodon ziprasidone • Open windows in the evening when the air Haldol haloperidol outside is cooler. illness in Invega paliperidone • Avoid outdoor activity during the warmest Lexapro escitalopram parts of the day. Loxitane loxapine Latuda lurasidone • Take a cool shower or bath. individuals Navane thiothixene When outside: Norpramin desipramine • Apply sunscreen. Paxil paroxetine • Avoid prolonged exposure to direct sunlight. using psychiatric Phenergan promethazine • Wear loose-fitting and light-colored Pristiq desvenlafaxine clothing. Prolixin fluphenazine medication Prozac fluoxetine • Wear a hat and sunglasses. Rexulti brexpiprazole • Be aware of your environment (For Risperdal risperidone example, asphalt may be warmer than Saphris asenapine surrounding air temperature). 2016 Seroquel quetiapine Sinequan, Silenor doxepin Stelazine trifluoperazine Thorazine chlorpromazine Ohio Department of Mental Tofranil imipramine Health and Addiction Services Trilafon perphenazine 30 E. Broad St., 36th Floor Wellbutrin, Zyban bupropion Columbus, Ohio 43215 Viibryd vilazodone www.mha.ohio.gov Vrylar cariprazine 1-877-275-6364 Zoloft sertraline John R.
    [Show full text]
  • High-Risk Medications in the Elderly
    High-Risk Medications in the Elderly The Centers for Medicare & Medicaid Services (CMS) contracted with the National Committee for Quality Assurance (NCQA) to develop clinical strategies to monitor and evaluate the quality of care provided to Medicare beneficiaries. The NCQA’s Geriatric Measurement Advisory Panel identified several categories of medications that have an increased risk of adverse effects to elderly patients. The enclosed chart identifies several key medication categories that CMS and NCQA are monitoring. In an effort to ensure patients’ safety, many of our clients have established pre-authorization protocols for those prescriptions for high risk medications in patients older than 65 years of age. Since pharmacists have a very important role in patient care, we want you to be part of this safety initiative. We strongly encourage that you contact the prescriber when your elderly patient is requesting a new or refilled prescription of a high-risk medication listed on the below chart. Category High Risk Medications Alternatives Analgesics butalbital/APAP Mild Pain: butalbital/APAP/caffeine (ESGIC, FIORICET) acetaminophen, codeine, short-term NSAIDs butalbital /APAP/caffeine/codeine Moderate/Severe Pain: butalbital/ASA/caffeine (FIORINAL) tramadol (ULTRAM), tramadol/APAP* (ULTRACET), butalbital/ASA/caffeine/codeine morphine sulfate (MS CONTIN), ketorolac (TORADOL) hydrocodone/APAP (VICODIN, etc.), oxycodone indomethacin (INDOCIN) (OXYIR), oxycodone/APAP (PERCOCET), fentanyl meperidina (DEMEROL) patch (DURAGESIC), OXYCONTIN
    [Show full text]
  • II.3.3 Tricyclic and Tetracyclic Antidepressants by Akira Namera and Mikio Yashiki
    3.3 II.3.3 Tricyclic and tetracyclic antidepressants by Akira Namera and Mikio Yashiki Introduction Many of antidepressants exert their eff ects by inhibiting the reuptake of norepinephrine and serotonin and by accerelating the release of them at synaptic terminals of neurons in the brain. As characteristic structures of such drugs showing antidepressive eff ects, many of them have tricyclic or tetracyclic nuclei; this is the reason why they are called “ tricyclic antidepressants or tetracyclic antidepressants”. Th ere are many cases of suicides using the antidepressants; their massive intake sometimes causes death. About 10 kinds of tricyclic and tetracyclic antidepressants are now being used in Japan (> Figure 3.1); among them, amitriptyline is best distributed [1, 2]. Recently, the use of tetracyclic antidepressants is increasing, because of their mild side eff ects and their high eff ectiveness with their small doses; the increase of their use is causing the increase of their poisoning cases. Although carbamazepine does not belong to the antidepressant group, its structure is very similar to those of tricyclic antidepressants; therefore, the drug is also in- cluded in this chapter. GC/MS analysis Reagents and their preparation • Amitriptyline, carbamazepine, clomipramine, desipramine, imipramine, maprotiline, mi- anserin, nortriptyline and trimipramine can be purchased from Sigma (St. Louis, MO, USA); pure powder of the following drugs was donated by each manufacturer: amoxapine by Takeda Chem. Ind. Ltd., Osaka, Japan; dosulepin by Kaken Pharmaceutical Co., Ltd., Tokyo, Japan; lofepramine by Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan; and setip- tiline by Mochida Pharmaceutical Co., Ltd., Tokyo, Japan. • A 20-g aliquot of sodium carbonate is dissolved in distilled water to prepare 100 mL solu- tion (20 %, w/v).
    [Show full text]